Filing Details

Accession Number:
0001587221-17-000034
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-08 16:24:44
Reporting Period:
2017-12-06
Accepted Time:
2017-12-08 16:24:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1587221 Zosano Pharma Corp ZSAN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1191287 Kenneth Greathouse C/O Zosano Pharma Corporation
34790 Ardentech Court
Fremont CA 94555
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-12-06 55,000 $0.61 200,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5987 to $0.6187, inclusive. The reporting person undertakes to provide to Zosano Pharma Corporation, any security holder of Zosano Pharma Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.